Abstract
The introduction of MALDI TOF mass spectrometry (MALDI TOF MS) in clinical microbiology at the end of 2010 has been a revolution for microbial identification [1]. Unlike the conventional uses of MALDI TOF MS in clinical chemistry laboratories, detecting and quantifying specific peaks of known proteins, the routine use of MALDI TOF MS in clinical microbiology is based on the comparison of mass spectra (intensity of m/z values corresponding to peptides in the low m/z region) to a database of mass spectra, allowing the attribution of matching scores without any a priori on the corresponding proteins.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
